Search result for 'takeda'

Granules India receives USFDA approval for its generic Lisdexamfetamine Dimesylate capsules, indicated for the treatment of ADHD and Binge Eating Disorder in adults and children.

Granules India's subsidiary receives USFDA approval for generic Lisdexamfetamine Dimesylate chewable tablets, a medication used to treat ADHD and binge eating disorder.

Lupin, a leading drug firm, has appointed Claus Jepsen as President of its Global Specialty business. Jepsen joins Lupin from Takeda Pharmaceuticals, where he led the Global Strategy for rare...

Lupin has entered into a patent license agreement with Takeda to commercialise Vonoprazan tablets, a novel gastrointestinal drug, in the Indian market. The drug will be marketed under the brand...

Alkem Laboratories has signed a licensing agreement with Takeda to commercialize Vonoprazan, a drug for reflux esophagitis and other gastrointestinal conditions, in India.

Dr Reddy's Laboratories has inked a licensing deal with Takeda Pharmaceutical to commercialize Vonoprazan tablets in India, a novel treatment for reflux esophagitis and other acid peptic disorders.

Zydus Lifesciences has signed a licensing deal with Takeda to market Vonoprazan, a P-CAB drug for GERD, in India under the brand name Vault.

Sun Pharma has partnered with Takeda to bring Vonoprazan, a novel gastrointestinal drug, to the Indian market. This partnership aims to provide patients with a new treatment option for reflux...

Alembic Pharmaceuticals receives USFDA approval for its generic Icatibant injection, a treatment for acute attacks of hereditary angioedema (HAE) in adults. This is the company's first peptide...

Torrent Pharmaceuticals has licensed Vonoprazan, a novel P-CAB for GERD treatment, from Takeda. The drug will be marketed in India under the brand name Kabvie.

Pharma industry leaders highlight India's rising attractiveness for clinical trials, citing recent reforms and a robust healthcare infrastructure. Learn about the factors driving this trend.

Japanese drug firm Takeda and Hyderabad-based Biological E team up to manufacture a dengue vaccine, aiming to increase global access and fight the disease.

Takeda and Biological E. Limited announce a partnership to increase production of Qdenga (Dengue Tetravalent Vaccine) to expand access in endemic countries by 2030.

Lupin receives USFDA approval to market generic Febuxostat tablets for the treatment of hyperuricemia in adults with gout. The drug, a generic equivalent of Uloric, will be manufactured in India.

Web Werks India will invest Rs 20,000 crore to build a data centre park in Bengaluru, Karnataka. The MoU was signed at the World Economic Forum in Davos.

Karnataka government signs MoUs worth Rs 22,000 crore with 7 companies at Davos WEF, including a Rs 20,000 crore data centre park by Web Werks.